{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:43:57Z","timestamp":1756460637327},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Radioisotope-labeled prostate-specific membrane antigen (PSMA) tracers have been proven accurate for detection of prostate cancer localizations. Uptake of those tracers in other malignant and benign lesions has been reported, including faint accumulation of <jats:sup>68<\/jats:sup>Ga-PSMA-HBED-CC in adrenal adenoma. A 77-year-old man with prostate carcinoma was scanned with <jats:sup>18<\/jats:sup>F-DCFPyL, a promising <jats:sup>18<\/jats:sup>F-labeled PSMA ligand, for prostate-specific antigen progression while on luteinizing hormone\u2013releasing hormone agonist therapy. The PET\/CT shows <jats:sup>18<\/jats:sup>F-DCFPyL uptake in bilateral enlarged adrenals. Non\u2013contrast-enhanced CT scan indicated left adrenal adenoma. Regarding the high positive predictive value of multiphase contrast-enhanced CT (98%), presence of right adrenal adenoma is also likely.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001808","type":"journal-article","created":{"date-parts":[[2017,8,20]],"date-time":"2017-08-20T02:12:06Z","timestamp":1503195126000},"page":"862-864","source":"Crossref","is-referenced-by-count":9,"title":["High 18Fluor-DCFPyL Uptake in Adrenal Adenomas"],"prefix":"10.1097","volume":"42","author":[{"given":"Johannes Gerrit Karel","family":"Peper","sequence":"first","affiliation":[{"name":"From the *Department of Nuclear Medicine and Radiology, Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar; and \u2020Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Srbljin","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and Radiology, Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar; and \u2020Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friso Martijn","family":"van der Zant","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and Radiology, Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar; and \u2020Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco Johannes Jacob","family":"Knol","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and Radiology, Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar; and \u2020Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurits","family":"Wondergem","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine and Radiology, Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar; and \u2020Department of Nuclear Medicine, Zaans Medisch Centrum, Zaandam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiol.2223010766","article-title":"Adrenal masses: characterization with combined unenhanced and delayed enhanced CT","volume":"222","year":"2002","journal-title":"Radiology"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s11255-012-0202-4","article-title":"The washout rate on the delayed CT image as a diagnostic tool for adrenal adenoma verified by pathology: a multicenter study","volume":"44","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium\u2013labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/ph7070779","article-title":"Novel preclinical and radiopharmaceutical aspects of [68Ga]ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer","volume":"7","year":"2014","journal-title":"Pharmaceuticals (Basel)"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline\u2013based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000001197","article-title":"68Ga-PSMA-PET\/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11307-016-0957-6","article-title":"PSMA-based [(18)F]DCFPyL PET\/CT is superior to conventional imaging for lesion detection in patients with metastatic prostate cancer","volume":"18","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11307-015-0866-0","article-title":"Comparison of [(18)F]DCFPyL and [(68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate cancer","volume":"17","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/1754-9485.12357","article-title":"Gallium-68 PSMA uptake in adrenal adenoma","volume":"60","year":"2016","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201711000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:02:05Z","timestamp":1695618125000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201711000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001808","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}